<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110525/" ref="ordinalpos=511&amp;ncbi_uid=6474942&amp;link_uid=PMC4110525" image-link="/pmc/articles/PMC4110525/figure/F5/" class="imagepopup">Figure 5.  From: Targeting Notch1 <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase family. </a></div><br /><div class="p4l_captionBody"><b>Notch1 signaling pathway regulated cisplatin sensitivity of MG63 and Saos-2 via changing the apoptosis effect.</b> After overexpression of NICD-1, cisplatin could induce more apoptosis in MG63 and Saos2 cells than their control group <b>(A and B)</b>. When Notch1 signaling pathway was inhibited by DAPT, cisplatin induced fewer apoptosis cells in both osteosarcoma cell lines <b>(C and D)</b>. (*P &lt; 0.05; **P &lt; 0.01).</div></div>